Inflamax Research Inc. is pleased to announce today that Dr. Anne Marie Salapatek has completed QuantumShift, a unique leadership development program and network sponsored by Ivey, KPMG Enterprise, TD, and The Globe and Mail.
London, Ontario (PRWEB) May 14, 2015
Boosting entrepreneurial talent is critical for our country’s future. Successful CEOs and business leaders from across Canada have just finished an intensive program at the Ivey Business School in London, Ontario. These entrepreneurs are on the way to taking their companies to the next level.
Helping private businesses grow and improve their productivity is essential to building a more competitive Canada. Ivey Business School and KPMG Enterprise realize this and for the 12th year they invited a select group of entrepreneurs to participate in QuantumShift, a rigorous week-long program to give them the tools to push their businesses forward.
QuantumShift is designed to help Canadian business owners accelerate their companies. It’s for entrepreneurs who are past the start-up stage and who are ready to innovate. The program focuses on how to lead an enterprise through exponential growth; how to attract and retain the best employees; how to uncover obstacles that may be limiting growth; how to value a venture and use strategies for moving from business plan to financial proposition; and how to build a strong network of entrepreneurial peers to share best-practices.
With this graduating class, almost 500 successful entrepreneurs have completed the QuantumShift program, including Cameron Heaps, co-founder of Steam Whistle Brewery. Heaps is passionate about growing the craft brewing industry in Canada and says QuantumShift provided him with a unique opportunity to rethink his company’s operating structure.
“When you’re a young company in a high growth phase, often the structures aren’t keeping up. This was an opportunity to step back and start identifying where the cracks are and how to set up your business to sustain growth,” said Heaps.
“Like Cameron, I am very pleased to have joined the prestigious ranks of the Quantum Shift alumni and to have been given this opportunity to participate and learn at the Ivey Business School,” said Anne Marie.
Dr. Salapatek is Inflamax Research’s President and Chief Scientific Officer, who said of the program, “The Quantum Shift program has given us the time to reflect, and the latest in business practices and case study, which will help us to continue to move our businesses forward. Equally important, I had the opportunity to meet other successful entrepreneurs from across Canada. This will have lasting impact for me, as I now also have expanded my network of colleagues and friends that I can access for ongoing business support.”
Inflamax Research is a full-service Global Clinical Research Organization CRO that specializes in allergy, asthma and ocular research with extensive experience in design and conduct of clinical trials. Inflamax offers Natural Environmental Exposure Chamber models and has a unique, patented mobile EEC model which can be located anywhere worldwide for use in multicenter trials.